BioInteractions first with body-friendly surface:
This article was originally published in Clinica
Executive Summary
BioInteractions has become the first UK company to receive US FDA clearance to market a biocompatible surface for oxygenators. The company developed the Trillium surface with US firm Avecor for its Affinity oxygenator. BioInteractions is collaborating in a number of programmes with major manufacturers to surface treat medical devices. These products should reach the market within the next three years, the company said.